The Molecular Biology Society of Japan

[2P-0513] Identification of a novel GBA mutation in Parkinson's disease and biochemical characterization of patient-derived lymphoblastoid cells

〇Yasuyo Suzuki1, Ayaka Chikada 2, Kimiko Katoh1, Kenichiro Yamada1, Daisuke Fukushi1, Hiroyuki Ishiura2, Kazushi Deguchi3, Jun Mitsui4, Shoji Tuji4, Nobuaki Wakamatsu5 (1.Dept of Genet, Inst for Develop Res, Aichi Human Serv Ctr, 2.Dept of Neurol, Univ of Tokyo, 3.Dept of Gastroenterol and Neurol, Faculty of Med, Kagawa Univ, 4.Dept of Mol Neurol, Univ of Tokyo, 5.Dept of Neurol, Neurol and Stroke Ctr, Takamatsu Municipal Hosp)

The 41st Annual Meeting of the Molecular Biology Society of Japan

[2P-0516] In silico drug screening by using genome-wide association study (GWAS)-data repurposed a novel disease-modifying drug for Parkinson’s disease

〇TAKESHI UENAKA1, WATARU SATAKE1, Pei-Chieng Cha1, HIDEKI HAYAKAWA2, KOUSUKE BABA2, SHIYING JIANG2, KAZUHIRO KOBAYASHI1, MOTOI KANAGAWA1, YUKINORI OKADA3,4, HIDEKI MOCHIZUKI2, TATSUSHI TODA5,1 (1.Div of Neurol/Mol Brain Sci, Kobe Univ Graduate School of Med, 2.Dep of Neurol, Osaka Univ Graduate School of Med, 3.Dep of Statistical Genetics, Osaka Univ Graduate School of Med, 4.Lab of Statistical Immunol, Immunol Frontier Research Center (WPI-IFReC), Osaka Univ, 5.Dep of Neurol, Graduate School of Med, The Univ of Tokyo)

The 41st Annual Meeting of the Molecular Biology Society of Japan

[2P-0517] Screening for Parkin activation drug

〇Kahori Shiba1, Tsuyoshi Inoshita1, Yuzuru Imai2, Nobutaka Hattori3 (1.Department of Treatment and Research in Multiple Sclerosis and Neuro-intractable Disease, Juntendo University Graduate School of Medicine, 2.Department of Research for Parkinson´s Disease, Juntendo University Graduate School of Medicine, 3.Department of Neurology, Juntendo University Graduate School of Medicine)

The 41st Annual Meeting of the Molecular Biology Society of Japan